Historical record - last NADAC effective date: 8/18/2021
Product Information
RIZATRIPTAN 5 MG ODT is a generic product labeled by Unichem Pharmaceuticals (USA) Inc., priced at $0.9852 per EA under NDC 29300026891. Its NADAC has been published 97 times since Oct 16, 2019.
FDA first approved this application on Mar 7, 2017.
Strength
5 mg/1
Manufacturer
Unichem Pharmaceuticals (USA) Inc.NDC
29300026891
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/18/2021
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
Generic (ANDA)
FDA Application
ANDA207835FDA Approved
3/7/2017
On Market Since
3/7/2017
Pharmacological Classes
Price Statistics
The NADAC for RIZATRIPTAN 5 MG ODT has been published 97 times since Oct 16, 2019, and over the history we have for it it has declined 3.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.9852 per EA |
|---|---|
| All-time high | $1.3658 (Dec 16, 2020) |
| All-time low | $0.9588 (Jul 21, 2021) |
| Median price | $1.1449 |
| Average price | $1.1261 |
| Largest weekly change | -26.6% (Dec 23, 2020) |
| Weeks tracked | 97 |
| Tracking since | Oct 16, 2019 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-3.7%
Last surveyed Aug 18, 2021 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Unichem Pharmaceuticals (USA) Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Rizatriptan Benzoate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of RIZATRIPTAN 5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for RIZATRIPTAN 5 MG ODT, manufactured by Unichem Pharmaceuticals (USA) Inc., is $0.9852 per EA (NDC 29300026891), effective Aug 18, 2021.
How has the price of RIZATRIPTAN 5 MG ODT changed over time?
Over the history we have for it, the NADAC for RIZATRIPTAN 5 MG ODT has declined 3.7%. It has been tracked across 97 weekly CMS publications since Oct 16, 2019.
What are the highest and lowest recorded NADAC prices for RIZATRIPTAN 5 MG ODT?
Since Oct 16, 2019, the NADAC for RIZATRIPTAN 5 MG ODT has ranged from a low of $0.9588 (Jul 21, 2021) to a high of $1.3658 (Dec 16, 2020), with a median of $1.1449 per EA.
Are there cheaper alternatives to RIZATRIPTAN 5 MG ODT?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 5 MG TABLET, is $0.3203 per EA — about 67% below RIZATRIPTAN 5 MG ODT.
Who manufactures RIZATRIPTAN 5 MG ODT?
RIZATRIPTAN 5 MG ODT (NDC 29300026891) is labeled by Unichem Pharmaceuticals (USA) Inc., and CMS classifies it as a generic product.